MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IGMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

IGM Biosciences (IGMS) Ownership - Who owns IGM Biosciences?

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
76.57M
P/E Ratio
N/A
Total Cash
104.31M
Projected Growth
N/A
Total Debt
N/A
Revenue
145.05M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
1.73
Total Debt/Equity
N/A
Revenue/Share
2.37 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IGMS
A.I. Advisor
published General Information

General Information

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology

Profile
Details
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com